JAMA Neurology Author Interviews
JAMA Network
Categories: Health
Add to My List
Listen to the last episode:
Interview with Rachel Grashow, PhD, MS, and Aaron L. Baggish, MD, authors of Perceived Chronic Traumatic Encephalopathy and Suicidality in Former Professional Football Players. Hosted by Cynthia E. Armand, MD. In the US, you can call, text, or chat 988, the Suicide and Crisis Lifeline. Related Content:
Previous episodes
-
111 - Perceived CTE in Former Professional Football PlayersMon, 23 Sep 2024 - 0h
-
110 - Localized Nicardipine Release Implants for Prevention of VasospasmMon, 19 Aug 2024 - 0h
-
109 - Direct-Acting OACs and Antiseizure Medications for AF and Epilepsy and Risk of Thromboembolic EventsMon, 08 Jul 2024 - 0h
-
108 - Early vs Late Anticoagulation in Minor, Moderate, and Major Ischemic Stroke With Atrial FibrillationTue, 28 May 2024 - 0h
-
107 - Association of New-Onset Seizures With SARS-CoV-2 VaccinesMon, 29 Apr 2024 - 0h
-
106 - High-Efficacy Therapy Discontinuation vs Continuation in Patients 50 Years and Older With Nonactive MSMon, 25 Mar 2024 - 0h
-
105 - Posttraumatic Epilepsy and Dementia RiskMon, 26 Feb 2024 - 0h
-
104 - Risk of Stroke and Myocardial Infarction Among Initiators of TriptansMon, 05 Feb 2024 - 0h
-
103 - Risk Factors for Young-Onset Dementia in the UK BiobankTue, 26 Dec 2023 - 0h
-
102 - Endovascular Therapy Outcomes by ASPECTS and Infarct Core Volume in Patients With Large InfarctMon, 27 Nov 2023 - 0h
-
101 - Neurofilament Light Chain Elevation and Disability Progression in Multiple SclerosisMon, 06 Nov 2023 - 0h
-
100 - Atrial Fibrillation In Patients With Stroke Attributed to Large- or Small-Vessel DiseaseMon, 30 Oct 2023 - 0h
-
99 - Neuropathologic and Clinical Findings in Athletes With Repetitive Head ImpactsMon, 28 Aug 2023 - 0h
-
98 - Dementia Risk and Disadvantaged NeighborhoodsWed, 19 Jul 2023 - 0h
-
97 - Automated Interpretation of Clinical Electroencephalograms Using Artificial IntelligenceTue, 20 Jun 2023 - 0h
-
96 - Risk of Parkinson Disease Among Camp Lejeune VeteransMon, 15 May 2023 - 0h
-
95 - Prenatal Exposure to Antiseizure Medication and Psychiatric DisordersMon, 17 Apr 2023 - 0h
-
94 - Association of Dementia Risk With Focal Epilepsy and Modifiable Cardiovascular Risk FactorsMon, 27 Mar 2023 - 0h
-
93 - Optimal Intensity and Duration of Walking Rehabilitation in Patients With Chronic StrokeThu, 23 Feb 2023 - 0h
-
92 - Endovascular Thrombectomy vs Medical Management Beyond 24 Hours of Last Known WellTue, 27 Dec 2022 - 0h
-
91 - Autoimmune Encephalitis Misdiagnosis in AdultsMon, 28 Nov 2022 - 0h
-
90 - Evaluation of Simvastatin as a Disease-Modifying Treatment for Patients With Parkinson DiseaseMon, 31 Oct 2022 - 0h
-
89 - Cancer Risk in Children of Mothers With Epilepsy and High-Dose Folic Acid Use During PregnancyMon, 26 Sep 2022 - 0h
-
88 - Association of Neurocritical Care With Outcomes for Adults With Brain InjuryMon, 29 Aug 2022 - 0h
-
87 - Efficacy of Benzodiazepines or Antihistamines for Patients With Acute VertigoMon, 18 Jul 2022 - 0h
-
86 - A Conversation With Dr Kirsten Bibbins-Domingo, JAMA’s New Editor in ChiefTue, 05 Jul 2022 - 0h
-
85 - Structural Inequities for Historically Underserved Communities in the Adoption of Stroke Certification in the USMon, 27 Jun 2022 - 0h
-
84 - Prenatal Exposure to Antiseizure Medication With Risk of Autism and Intellectual DisabilityTue, 31 May 2022 - 0h
-
83 - Postmortem Assessment of Olfactory Tissue Degeneration and Microvasculopathy in Patients With COVID-19Mon, 11 Apr 2022 - 0h
-
82 - Early Posttraumatic Seizures and Moderate to Severe Traumatic Brain InjuryMon, 21 Feb 2022 - 0h
-
81 - Infarct on Brain Imaging, Subsequent Ischemic Stroke, and Clopidogrel-Aspirin EfficacyTue, 18 Jan 2022 - 0h
-
80 - Assessment of Erenumab Safety and Efficacy in Migraine With and Without AuraMon, 20 Dec 2021 - 0h
-
79 - Association of Plasma p-tau181 and p-tau231 Concentrations With Cognitive Decline in Probable Dementia With Lewy BodiesMon, 22 Nov 2021 - 0h
-
78 - Association of Increased Seizures During Rewarming With Abnormal Neurodevelopmental Outcomes at 2-Year Follow-upMon, 18 Oct 2021 - 0h
-
77 - Use and Safety of Immunotherapeutic Management of N-Methyl-D-Aspartate Receptor Antibody EncephalitisMon, 20 Sep 2021 - 0h
-
76 - Risk of Rupture After Intracranial Aneurysm GrowthMon, 30 Aug 2021 - 0h
-
75 - Seizure Prophylaxis After Spontaneous Intracerebral HemorrhageMon, 26 Jul 2021 - 0h
-
74 - Tau PET as a Prognostic MarkerMon, 28 Jun 2021 - 0h
-
73 - Association of Nitrogen Dioxide and Other Air Pollution Exposures With the Risk of Parkinson DiseaseMon, 17 May 2021 - 0h
-
72 - Effect of High-Frequency (10 kHz) Spinal Cord Stimulation in Patients With Painful Diabetic NeuropathyMon, 05 Apr 2021 - 0h
-
71 - Reperfusion Treatment and Stroke Outcomes in Hospitals with Telestroke CapacityMon, 01 Mar 2021 - 0h
-
70 - Agent Orange Exposure and Dementia Diagnosis in US Veterans of the Vietnam EraMon, 25 Jan 2021 - 0h
-
69 - Assessment of Botulinum Neurotoxin Injection for Dystonic Hand TremorMon, 21 Dec 2020 - 0h
-
68 - Prehospital Prediction of Large Anterior Vessel OcclusionMon, 30 Nov 2020 - 0h
-
67 - ED and Inpatient Use and Costs in Adult and Pediatric Functional Neurological DisordersMon, 26 Oct 2020 - 0h
-
66 - Optic Neuritis Incidence and Prevalence and Association With Systemic and Neurologic DiseaseMon, 05 Oct 2020 - 0h
-
65 - Intensive Systolic Blood Pressure Reduction in Intracerebral HemorrhageMon, 31 Aug 2020 - 0h
-
64 - Continuous vs Routine Electroencephalogram in Critically Ill Adults With Altered ConsciousnessMon, 27 Jul 2020 - 0h
-
63 - Intranasal Insulin for the Treatment of Mild Cognitive Impairment and Alzheimer Disease DementiaMon, 22 Jun 2020 - 0h
-
62 - Viltolarsen in Boys With Duchenne Muscular Dystrophy Amenable to Exon 53 SkippingTue, 26 May 2020 - 0h
Show more episodes
5
